Literature DB >> 14715532

G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.

Gerda E Breitwieser1.   

Abstract

The cardiovascular system is richly endowed with G protein-coupled receptors (GPCRs), members of the largest family of plasma membrane-localized receptors. During the last 10 years, it has become increasingly clear that many, if not all, GPCRs function in oligomeric complexes, as either homo- or hetero-oligomers. This review explores the mechanistic implications of GPCR dimerization and/or oligomerization on receptor activation and interactions with G proteins. The effects of GPCR oligomerization on receptor pharmacology, GPCR-mediated signaling, and potential contributions to GPCR crosstalk will be considered in the context of receptors important in the cardiovascular system. Our evolving understanding of the structural and functional consequences of GPCR oligomerization may provide novel and more selective sites for pharmacological tuning of cardiovascular function.

Mesh:

Substances:

Year:  2004        PMID: 14715532     DOI: 10.1161/01.RES.0000110420.68526.19

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  54 in total

1.  Nuclear localization drives α1-adrenergic receptor oligomerization and signaling in cardiac myocytes.

Authors:  Casey D Wright; Steven C Wu; Erika F Dahl; Alan J Sazama; Timothy D O'Connell
Journal:  Cell Signal       Date:  2011-11-18       Impact factor: 4.315

Review 2.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  Evidence that prokineticin receptor 2 exists as a dimer in vivo.

Authors:  Sara Marsango; Maria Carmela Bonaccorsi di Patti; Donatella Barra; Rossella Miele
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

5.  A hypothesis for GPCR activation.

Authors:  Jerzy Ciarkowski; Magdalena Witt; Rafał Slusarz
Journal:  J Mol Model       Date:  2005-05-12       Impact factor: 1.810

6.  Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor.

Authors:  Damien Thévenin; Tzvetana Lazarova; Matthew F Roberts; Clifford R Robinson
Journal:  Protein Sci       Date:  2005-06-29       Impact factor: 6.725

Review 7.  How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics.

Authors:  Luigi F Agnati; Diego Guidolin; Susanna Genedani; Sergi Ferré; Albertino Bigiani; Amina S Woods; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

8.  Diffusion-limited reactions in G-protein activation: unexpected consequences of antagonist and agonist competition.

Authors:  Christopher J Brinkerhoff; Ji Sun Choi; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2008-01-11       Impact factor: 2.691

9.  Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.

Authors:  Kaleeckal G Harikumar; Laurence J Miller
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

10.  Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice.

Authors:  Yan Liang; Dimitrios Fotiadis; Tadao Maeda; Akiko Maeda; Anna Modzelewska; Slawomir Filipek; David A Saperstein; Andreas Engel; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.